BACKGROUND: Epidemiological studies suggest that proxies of higher lifetime estrogen exposure are associated with better cognitive function in postmenopausal women, but this has not been found consistently. OBJECTIVE: To determine whether reproductive history, an important modifier of estrogen exposure across the lifetime, is associated with risk of cognitive impairment in postmenopausal women. METHODS: We analyzed the baseline data from Zhejiang Major Public Health Surveillance Program (ZPHS) including 4,796 postmenopausal women. Cognitive impairment was assessed through the application of Mini-Mental State Examination questionnaire. Logistic regression models, controlled for an extensive range of potential confounders, were generated to examine the associations between women's reproductive history and risk of cognitive impairment in their later life. RESULTS: The length of reproductive period was inversely associated with risk of cognitive impairment (p = 0.001). Odds ratio (OR) of cognitive impairment were 1.316 (95% CI 1.095∼1.582) for women with 5 or more times of full-term pregnancies, compared with those with 1∼4 times of full-term pregnancies. Women without incomplete pregnancy had a significant higher risk of cognitive impairment (OR = 1.194, 95% CI 1.000∼1.429), compared with the reference (1∼2 times of incomplete pregnancies). Oral contraceptive use (OR = 0.489, 95% CI 0.263∼0.910) and intrauterine device (IUD) use (OR = 0.684, 95% CI 0.575∼0.815) were associated with significantly reduced risk of cognitive impairment. CONCLUSION: Our results indicated that shorter reproductive period, higher number of full-term pregnancies and no incomplete pregnancy history were associated with an increased risk of cognitive impairment. In contrast, oral contraceptive and IUD use corresponded to reduced risk of cognitive impairment.
BACKGROUND: Epidemiological studies suggest that proxies of higher lifetime estrogen exposure are associated with better cognitive function in postmenopausal women, but this has not been found consistently. OBJECTIVE: To determine whether reproductive history, an important modifier of estrogen exposure across the lifetime, is associated with risk of cognitive impairment in postmenopausal women. METHODS: We analyzed the baseline data from Zhejiang Major Public Health Surveillance Program (ZPHS) including 4,796 postmenopausal women. Cognitive impairment was assessed through the application of Mini-Mental State Examination questionnaire. Logistic regression models, controlled for an extensive range of potential confounders, were generated to examine the associations between women's reproductive history and risk of cognitive impairment in their later life. RESULTS: The length of reproductive period was inversely associated with risk of cognitive impairment (p = 0.001). Odds ratio (OR) of cognitive impairment were 1.316 (95% CI 1.095∼1.582) for women with 5 or more times of full-term pregnancies, compared with those with 1∼4 times of full-term pregnancies. Women without incomplete pregnancy had a significant higher risk of cognitive impairment (OR = 1.194, 95% CI 1.000∼1.429), compared with the reference (1∼2 times of incomplete pregnancies). Oral contraceptive use (OR = 0.489, 95% CI 0.263∼0.910) and intrauterine device (IUD) use (OR = 0.684, 95% CI 0.575∼0.815) were associated with significantly reduced risk of cognitive impairment. CONCLUSION: Our results indicated that shorter reproductive period, higher number of full-term pregnancies and no incomplete pregnancy history were associated with an increased risk of cognitive impairment. In contrast, oral contraceptive and IUD use corresponded to reduced risk of cognitive impairment.
Entities:
Keywords:
Cognitive impairment; estrogen; intrauterine device; pregnancies; reproductive history
Authors: Steven Jett; Eva Schelbaum; Grace Jang; Camila Boneu Yepez; Jonathan P Dyke; Silky Pahlajani; Roberta Diaz Brinton; Lisa Mosconi Journal: Front Aging Neurosci Date: 2022-07-19 Impact factor: 5.702
Authors: Joon Hyung Jung; Ga Won Lee; Jun Ho Lee; Min Soo Byun; Dahyun Yi; So Yeon Jeon; Gi Jung Jung; Haejung Joung; Seong A Shin; Yu Kyeong Kim; Koung Mi Kang; Chul-Ho Sohn; Dong Young Lee Journal: Front Aging Neurosci Date: 2020-06-03 Impact factor: 5.750
Authors: J B Bae; D M Lipnicki; J W Han; P S Sachdev; T H Kim; K P Kwak; B J Kim; S G Kim; J L Kim; S W Moon; J H Park; S-H Ryu; J C Youn; D Y Lee; D W Lee; S B Lee; J J Lee; J H Jhoo; I Skoog; J Najar; T R Sterner; N Scarmeas; M Yannakoulia; E Dardiotis; S Riedel-Heller; S Roehr; A Pabst; D Ding; Q Zhao; X Liang; A Lobo; C De-la-Cámara; E Lobo; K W Kim Journal: Epidemiol Psychiatr Sci Date: 2020-10-20 Impact factor: 6.892
Authors: Fan He; Tian Li; Junfen Lin; Fudong Li; Yujia Zhai; Tao Zhang; Xue Gu; Genming Zhao Journal: Int J Environ Res Public Health Date: 2020-02-21 Impact factor: 3.390